Debevoise & Plimpton LLP
Fried, Frank, Harris, Shriver & Jacobson LLP
Mark is an accomplished and versatile corporate and transactional attorney in the life sciences industry, providing his clients with over 25 years of experience. His background includes advising, structuring, drafting and negotiating strategic transactions at all stages of the product lifecycle - from research and development through commercialization.
Mark began his career as an attorney at a top tier international law firm in New York focusing on M&A, securities law and structured finance transactions. He then spent over 17 years in-house at Pfizer, where he handled several high profile business transactions; advised C-suite executives and senior leadership teams for Pfizer’s R&D organization; and led a team of attorneys focused on advising, structuring, drafting and negotiating sophisticated and complex life sciences transactions for over a decade.
Mark has a firm working grasp of the science behind emerging technologies and product modalities, including RNAi and gene therapy, and an acute sensitivity to the business dynamics driving a myriad of life sciences transaction structures.
Senior In-house Counsel
A representative list of Mark’s transactional matters at Pfizer include:
Joe is or has been involved in a wide range of philanthropic and community organizations, including:
Joe has spoken on business law and ethics at the Massachusetts Institute of Technology (Program of Health Sciences and Technology), Ross School of Business at the University of Michigan (Net Impact Conference), and Boston College Law School.
Joe was a member of the National Finance Council and actively involved in the voter protection team for the Stacey Abrams for Governor campaign.